Gary Tanner

Pharma

Valeant has wrapped up a couple of shareholder lawsuits it inherited with its purchase of Salix. But it’s now millions of dollars deeper in the hole.

Carly Helfand , Eric Sagonowsky Mar 2, 2017 7:57am